Sabal Therapeutics LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sabal Therapeutics LLC - overview
Established
2016
Location
Watkinsville, GA, US
Primary Industry
Pharmaceuticals
About
Established in 2016 and based in Georgia, US, Sabal Therapeutics LLC operates as a pharmaceutical company. The company was founded by its president and CEO, Jeff Bryant. In July 2024, Rosemont Pharmaceuticals Limited, a portfolio company of Inflexion Private Equity Partners, acquired Sabal Therapeutics LLC. Sabal Therapeutics offers a range of outsourced services focused on sales and marketing management.
These services include sales management, regulatory Compliance, accounting and back-office services, product launch, sales commercialization, and multi-channel product marketing. The firm helps pharmaceutical companies by providing expertise and resources to optimize their sales and marketing efforts. Following the July 2024 acquisition the company plans to expand its market across the US and product offerings.
Current Investors
Rosemont Pharmaceuticals Limited
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.sabaltherapeutics.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Sabal Therapeutics LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Sabal Therapeutics LLC | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.